E. MATARACI KARA Et Al. , "In vitro activities of ceftazidime/avibactam, fosfomycin alone and ceftazidime/avibactam+fosfomycin combination against carbapenem-susceptible and -resistant Escherichia coli strains isolated from intensive care units," 29th European Congress of Clinical Microbiology and Infectious Diseases , vol.1, Amsterdam, Netherlands, pp.1, 2019
MATARACI KARA, E. Et Al. 2019. In vitro activities of ceftazidime/avibactam, fosfomycin alone and ceftazidime/avibactam+fosfomycin combination against carbapenem-susceptible and -resistant Escherichia coli strains isolated from intensive care units. 29th European Congress of Clinical Microbiology and Infectious Diseases , (Amsterdam, Netherlands), 1.
MATARACI KARA, E., YILMAZ, M., & ÖZBEK ÇELİK, B., (2019). In vitro activities of ceftazidime/avibactam, fosfomycin alone and ceftazidime/avibactam+fosfomycin combination against carbapenem-susceptible and -resistant Escherichia coli strains isolated from intensive care units . 29th European Congress of Clinical Microbiology and Infectious Diseases (pp.1). Amsterdam, Netherlands
MATARACI KARA, Emel, MESUT YILMAZ, And Berna ÖZBEK ÇELİK. "In vitro activities of ceftazidime/avibactam, fosfomycin alone and ceftazidime/avibactam+fosfomycin combination against carbapenem-susceptible and -resistant Escherichia coli strains isolated from intensive care units," 29th European Congress of Clinical Microbiology and Infectious Diseases, Amsterdam, Netherlands, 2019
MATARACI KARA, Emel M. Et Al. "In vitro activities of ceftazidime/avibactam, fosfomycin alone and ceftazidime/avibactam+fosfomycin combination against carbapenem-susceptible and -resistant Escherichia coli strains isolated from intensive care units." 29th European Congress of Clinical Microbiology and Infectious Diseases , Amsterdam, Netherlands, pp.1, 2019
MATARACI KARA, E. YILMAZ, M. And ÖZBEK ÇELİK, B. (2019) . "In vitro activities of ceftazidime/avibactam, fosfomycin alone and ceftazidime/avibactam+fosfomycin combination against carbapenem-susceptible and -resistant Escherichia coli strains isolated from intensive care units." 29th European Congress of Clinical Microbiology and Infectious Diseases , Amsterdam, Netherlands, p.1.
@conferencepaper{conferencepaper, author={Emel MATARACI KARA Et Al. }, title={In vitro activities of ceftazidime/avibactam, fosfomycin alone and ceftazidime/avibactam+fosfomycin combination against carbapenem-susceptible and -resistant Escherichia coli strains isolated from intensive care units}, congress name={29th European Congress of Clinical Microbiology and Infectious Diseases}, city={Amsterdam}, country={Netherlands}, year={2019}, pages={1} }